DOI QR코드

DOI QR Code

Anti-adipogenic and Pro-osteoblastogenic Activities of Spergularia marina Extract

  • Karadeniz, Fatih (Marine Biotechnology Center for Pharmaceuticals and Foods, Silla University) ;
  • Kim, Jung-Ae (Marine Biotechnology Center for Pharmaceuticals and Foods, Silla University) ;
  • Ahn, Byul-Nim (Department of Organic Material Science and Engineering, Pusan National University) ;
  • Kim, Mihyang (Department of Food and Nutrition, College of Medical and Life Science, Silla University) ;
  • Kong, Chang-Suk (Department of Food and Nutrition, College of Medical and Life Science, Silla University)
  • Received : 2014.07.22
  • Accepted : 2014.09.14
  • Published : 2014.09.30

Abstract

This is an Open Access article distributed under the terms of the Creative Commons Attribution For decades, Spergularia marina, a local food that is popular in South Korea, has been regarded as a nutritious source of amino acids, vitamins, and minerals. While several halophytes are reported to possess distinct bioactivities, S. marina has yet to be promoted as a natural source of bioactives. In this study, the effects of S. marina on the adipogenic differentiation of 3T3-L1 fibroblasts and the osteoblastic differentiation of MC3T3-E1 pre-osteoblasts and C2C12 myoblast cells were evaluated. The anti-adipogenic effect of S. marina was assessed by measuring lipid accumulation and adipogenic differentiation marker expression. S. marina treatment significantly reduced lipid accumulation and notably decreased the gene levels of peroxisome proliferator-activated receptor ${\gamma}$, CCAAT/enhancer-binding protein ${\alpha}$, and sterol regulatory element binding protein 1c. In addition, S. marina enhanced osteoblast differentiation, as indicated by increased alkaline phosphatase activity and increased levels of osteoblastogenesis indicators, namely bone morphogenetic protein-2, osteocalcin, and type I collagen. In conclusion, S. marina could be a source of functional food ingredients that improve osteoporosis and obesity. Further studies, including activity-based fractionation, will elucidate the mechanism of action and active ingredients of S. marina, which would provide researchers with a better understanding of the nutraceutical and therapeutic applications of S. marina.

References

  1. de las Heras B, Slowing K, Benedi J, Carretero E, Ortega T, Toledo C, Bermejo P, Iglesias I, Abad MJ, Gomez-Serranillos P, Liso PA, Villar A, Chiriboga X. 1998. Antiinflammatory and antioxidant activity of plants used in traditional medicine in Ecuador. J Ethnopharmacol 61: 161-166. https://doi.org/10.1016/S0378-8741(98)00029-4
  2. Schinella GR, Tournier HA, Prieto JM, Mordujovich de Buschiazzo P, Rios JL. 2002. Antioxidant activity of antiinflammatory plant extracts. Life Sci 70: 1023-1033. https://doi.org/10.1016/S0024-3205(01)01482-5
  3. Meot-Duros L, Le Floch G, Magne C. 2008. Radical scavenging, antioxidant and antimicrobial activities of halophytic species. J Ethnopharmacol 116: 258-262. https://doi.org/10.1016/j.jep.2007.11.024
  4. Talhouk RS, Karam C, Fostok S, El-Jouni W, Barbour EK. 2007. Anti-inflammatory bioactivities in plant extracts. J Med Food 10: 1-10. https://doi.org/10.1089/jmf.2005.055
  5. Flowers TJ, Colmer TD. 2008. Salinity tolerance in halophytes. New Phytol 179: 945-963. https://doi.org/10.1111/j.1469-8137.2008.02531.x
  6. Ksouri R, Megdiche W, Falleh H, Trabelsi N, Boulaaba M, Smaoui A, Abdelly C. 2008. Influence of biological, environmental and technical factors on phenolic content and antioxidant activities of Tunisian halophytes. C R Biol 331: 865-873. https://doi.org/10.1016/j.crvi.2008.07.024
  7. De Tommasi N, Piacente S, Gacs-Baitz E, De Simone F, Pizza C, Aquino R. 1998. Triterpenoid saponins from Spergularia ramosa. J Nat Prod 61: 323-327. https://doi.org/10.1021/np970398l
  8. Jouad H, Lacaille-Dubois MA, Lyoussi B, Eddouks M. 2001. Effects of the flavonoids extracted from Spergularia purpurea Pers. on arterial blood pressure and renal function in normal and hypertensive rats. J Ethnopharmacol 76: 159-163. https://doi.org/10.1016/S0378-8741(01)00209-4
  9. Lee JJ, Jung HO. 2012. Changes in physicochemical properties of Spergularia marina Griseb by blanching. Korean J Food Preserv 19: 866-872. https://doi.org/10.11002/kjfp.2012.19.6.866
  10. Muruganandan S, Roman AA, Sinal CJ. 2009. Adipocyte differentiation of bone marrow-derived mesenchymal stem cells: cross talk with the osteoblastogenic program. Cell Mol Life Sci 66: 236-253. https://doi.org/10.1007/s00018-008-8429-z
  11. Nuttall ME, Gimble JM. 2004. Controlling the balance between osteoblastogenesis and adipogenesis and the consequent therapeutic implications. Curr Opin Pharmacol 4: 290-294. https://doi.org/10.1016/j.coph.2004.03.002
  12. Kocic J, Santibanez JF, Krstic A, Mojsilovic S, Dordevic IO, Trivanovic D, Ilic V, Bugarski D. 2012. Interleukin 17 inhibits myogenic and promotes osteogenic differentiation of C2C12 myoblasts by activating ERK1,2. Biochim Biophys Acta 1823: 838-849. https://doi.org/10.1016/j.bbamcr.2012.01.001
  13. Grey A, Bolland M, Gamble G, Wattie D, Horne A, Davidson J, Reid IR. 2007. The peroxisome proliferator-activated receptor-$\gamma$ agonist rosiglitazone decreases bone formation and bone mineral density in healthy postmenopausal women: a randomized, controlled trial. J Clin Endocrinol Metab 92: 1305-1310. https://doi.org/10.1210/jc.2006-2646
  14. Gimble JM, Nuttall ME. 2012. The relationship between adipose tissue and bone metabolism. Clin Biochem 45: 874-879. https://doi.org/10.1016/j.clinbiochem.2012.03.006
  15. Chen F, Xiong H, Wang J, Ding X, Shu G, Mei Z. 2013. Antidiabetic effect of total flavonoids from Sanguis draxonis in type 2 diabetic rats. J Ethnopharmacol 149: 729-736. https://doi.org/10.1016/j.jep.2013.07.035
  16. Rosen CJ, Bouxsein ML. 2006. Mechanisms of Disease: is osteoporosis the obesity of bone? Nat Clin Pract Rheumatol 2: 35-43. https://doi.org/10.1038/ncprheum0070
  17. Ryoo HM, Lee MH, Kim YJ. 2006. Critical molecular switches involved in BMP-2-induced osteogenic differentiation of mesenchymal cells. Gene 366: 51-57. https://doi.org/10.1016/j.gene.2005.10.011
  18. Cheng SL, Shao JS, Charlton-Kachigian N, Loewy AP, Towler DA. 2003. Msx2 promotes osteogenesis and suppresses adipogenic differentiation of multipotent mesenchymal progenitors. J Biol Chem 278: 45969-45977. https://doi.org/10.1074/jbc.M306972200
  19. Hoemann CD, El-Gabalawy H, McKee MD. 2009. In vitro osteogenesis assays: Influence of the primary cell source on alkaline phosphatase activity and mineralization. Pathol Biol 57: 318-323. https://doi.org/10.1016/j.patbio.2008.06.004
  20. Aziz A, Miyake T, Engleka KA, Epstein JA, McDermott JC. 2009. Menin expression modulates mesenchymal cell commitment to the myogenic and osteogenic lineages. Dev Biol 332: 116-130. https://doi.org/10.1016/j.ydbio.2009.05.555

Cited by

  1. A phenyl lipid alkaloid and flavone C-diglucosides from Spergularia marina vol.25, pp.1, 2016, https://doi.org/10.1007/s10068-016-0009-7
  2. Changes in Antioxidant and Cancer Cell Growth Inhibitory Activities of Spergularia marina Griseb Extract according to Different Cooking Methods vol.33, pp.6, 2017, https://doi.org/10.9724/kfcs.2017.33.6.673